Savaria Posts 8.4% Revenue Growth in Q2 2026, Expands Margins
Event summary
- Savaria reported $245.8M in Q2 revenue, up 8.4% YoY, driven by 6.6% organic growth and 0.8% from acquisitions.
- Gross profit rose to $97.3M (39.6% margin), a 60 bps increase from Q2 2025.
- Operating income surged 34.1% YoY to $35.8M, with adjusted EBITDA reaching $51.8M.
- Net debt decreased to $172.8M, lowering the net debt-to-adjusted EBITDA ratio to 0.87 from 1.03 at year-end 2025.
The big picture
Savaria's Q2 results reflect strong execution in its accessibility and patient care segments, benefiting from an aging population and strategic acquisitions. The company's focus on operational efficiency through Savaria One and geographic diversification positions it well to capitalize on industry tailwinds. However, sustaining margin expansion and integrating new acquisitions will be key challenges.
What we're watching
- Integration Success
- How Savaria will integrate Vipal S.p.A to drive growth in European markets.
- Margin Sustainability
- Whether the company can maintain its expanded margins amid rising operational costs.
- Debt Management
- The pace at which Savaria reduces net debt while pursuing further acquisitions.
Related topics